Literature DB >> 24990321

Sphingosine-1-phosphate induces thrombin receptor PAR-4 expression to enhance cell migration and COX-2 formation in human monocytes.

Shailaja Mahajan-Thakur1, Björn D Sostmann2, Anke C Fender2, Daniel Behrendt3, Stephan B Felix4, Karsten Schrör2, Bernhard H Rauch5.   

Abstract

Thrombin is not only a central factor in blood coagulation but also stimulates inflammatory processes, including monocyte responses, via activation of PARs. The signaling lipid S1P is a major determinant of monocyte function. Here, we established an interaction between S1P and human monocyte responses to thrombin. S1P induced PAR-1 and PAR-4 mRNA and total protein expression in human monocytes and U937 cells in a concentration (0.1-10 μM)- and time (1-24 h)-dependent manner, respectively. However, only PAR-4 cell-surface expression was increased significantly by S1P, whereas PAR-1 remained unaffected. This response was associated with activation of the Akt, Erk, and p38 pathway and induction of COX-2 but not COX-1. PAR-4-mediated induction of COX-2 was prevented by the PI3K inhibitor LY (10 μM). Preincubation of human monocytes with S1P (1 μM; 16 h) resulted in an enhanced chemotaxis toward thrombin or to selective AP for PAR-4 but not PAR-1. Furthermore, down-regulation of PAR-4 transcription with siRNA attenuated the chemotactic response to thrombin and AP4. In conclusion, S1P enhances monocyte responses to thrombin via up-regulation of PAR-4 expression, which promotes cell migration and COX-2 abundance. This mechanism may facilitate monocyte recruitment to sites of vessel injury and inflammation.
© 2014 Society for Leukocyte Biology.

Entities:  

Keywords:  cyclooxygenase-2; monocytes; protease-activated receptors

Mesh:

Substances:

Year:  2014        PMID: 24990321     DOI: 10.1189/jlb.3AB1013-567R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  8 in total

1.  Thrombin receptor PAR4 drives canonical NLRP3 inflammasome signaling in the heart.

Authors:  Anke C Fender; Sonja Kleeschulte; Svenja Stolte; Katja Leineweber; Markus Kamler; Johannes Bode; Na Li; Dobromir Dobrev
Journal:  Basic Res Cardiol       Date:  2020-01-07       Impact factor: 17.165

2.  FTY720 ameliorates renal fibrosis by simultaneously affecting leucocyte recruitment and TGF-β signalling in fibroblasts.

Authors:  T Tian; J Zhang; X Zhu; S Wen; D Shi; H Zhou
Journal:  Clin Exp Immunol       Date:  2017-07-27       Impact factor: 4.330

3.  HuR mediates motility of human bone marrow-derived mesenchymal stem cells triggered by sphingosine 1-phosphate in liver fibrosis.

Authors:  Na Chang; Jingjing Ge; Lei Xiu; Zhongxin Zhao; Xianghui Duan; Lei Tian; Jieshi Xie; Lin Yang; Liying Li
Journal:  J Mol Med (Berl)       Date:  2016-08-20       Impact factor: 4.599

Review 4.  Sphingosine 1-phosphate (S1P) signaling in glioblastoma multiforme-A systematic review.

Authors:  Shailaja Mahajan-Thakur; Sandra Bien-Möller; Sascha Marx; Henry Schroeder; Bernhard H Rauch
Journal:  Int J Mol Sci       Date:  2017-11-17       Impact factor: 5.923

Review 5.  Signaling Crosstalk of TGF-β/ALK5 and PAR2/PAR1: A Complex Regulatory Network Controlling Fibrosis and Cancer.

Authors:  Hendrik Ungefroren; Frank Gieseler; Roland Kaufmann; Utz Settmacher; Hendrik Lehnert; Bernhard H Rauch
Journal:  Int J Mol Sci       Date:  2018-05-24       Impact factor: 5.923

Review 6.  New extracellular factors in glioblastoma multiforme development: neurotensin, growth differentiation factor-15, sphingosine-1-phosphate and cytomegalovirus infection.

Authors:  Jan Korbecki; Izabela Gutowska; Ireneusz Kojder; Dariusz Jeżewski; Marta Goschorska; Agnieszka Łukomska; Anna Lubkowska; Dariusz Chlubek; Irena Baranowska-Bosiacka
Journal:  Oncotarget       Date:  2018-01-09

Review 7.  Sphingosine-1-Phosphate and Its Receptors: A Mutual Link between Blood Coagulation and Inflammation.

Authors:  Shailaja Mahajan-Thakur; Andreas Böhm; Gabriele Jedlitschky; Karsten Schrör; Bernhard H Rauch
Journal:  Mediators Inflamm       Date:  2015-10-29       Impact factor: 4.711

8.  Doxorubicin-loaded cell-derived nanovesicles: an alternative targeted approach for anti-tumor therapy.

Authors:  Wei Jiang Goh; Choon Keong Lee; Shui Zou; Esther Cy Woon; Bertrand Czarny; Giorgia Pastorin
Journal:  Int J Nanomedicine       Date:  2017-04-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.